- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 12.09M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.32M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $3.84M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $4.26M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.97M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.79M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $13.24M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $13.05M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.18M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.45M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $20.05M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $20.29M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$482K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $148K |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $183K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$962K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$771K |